Resumen

Objectives: A longitudinal, randomized, single blind study was done to evaluate the efficacy of an antibacterial hybrid molecule (β-lactamic-fluoroquinolone) named cephalone after biliary-enteric-bypass (BEB). Material and methods: Four groups of mongrel dogs were operated on three consecutive periods. Cultures of bile and liver were obtained and assessed, followed by obliteration of common bile duct and BEB to groups A, B and C. Group D served as a control. Ten days later the group A received conventional treatment based on ampicillin/gentamicin and groups B and C, cephalone in two different concentration schemes during 10 consecutive days. Further samples were processed for bacteria and additional liver biopsies were obtained for histopathological analysis. Results: All three treatments reverted bacterial contamination in the liver and most of the bile samples were negative or showed a significant decrease in the number of colony forming units (p = 0.002). Histopathological analysis proved no lesions. Conclusions: Comparison of efficacy among antibacterial treatments revealed undistinguishable efficacy in this short-term assessment of bacterial contamination after BEB in dogs. The use of cephalone could be considered as a viable treatment or prophylaxis in bacterial infections occurring after BEB. Further studies are needed to assess longterm impact of the cephalone in this setting.

Palabras clave: Biliary atresia cephalone biliary-entericbypass (beb) colangitis.

2014-11-06   |   418 visitas   |   Evalua este artículo 0 valoraciones

Vol. 64 Núm.2. Marzo-Abril 2012 Pags. 173-181 Rev Invest Clin 2012; 64(2-ENGLISH)